Visiopharm
The company provides AI-driven precision pathology software for research and diagnostic applications. Its platform includes tools for spatial biology, multiplexed image analysis, and IVDR-certified biomarker assessment for cancers such as breast, lung, and prostate. The software serves pathologists, research scientists, and pharmaceutical companies by automating tissue analysis and ensuring IHC staining consistency.
Healthtech
Healthcare
Biotechnology
Pharmaceuticals
Diagnostics
Funding summary
- Total raised
- €12.7M
- Funding rounds
- 1
- Exit
- acquisition
- Exit value
- —
Investors in Visiopharm
Investors on record for Visiopharm. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Visiopharm?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors